Trial intelligence / Profile preview

Anakinra in Corticosteroid-Resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

NCT03587701Phase 2Recruiting

Sponsor
Northwell Health
Start
Jan 2019
Primary completion
Dec 2026
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in Meniere's disease (MD), autoimmune inner ear disease (AIED), sponsored by Northwell Health. Started Jan 2019; status: recruiting.

02

Drugs

anakinra
03

Conditions

Meniere's disease (MD)autoimmune inner ear disease (AIED)

Beyond the preview

Go deeper on NCT03587701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03587701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call